Other
ARC Act of 2025
This bill requires Medicare and Medicaid to fully cover screenings for peripheral artery disease (PAD)—a circulatory condition caused by blocked leg arteries—with no copays or deductibles for at-risk patients. It authorizes $6 million annually from 2026 through 2030 for public health campaigns and doctor education to help identify the disease early and prevent avoidable amputations. In addition, the legislation ties Medicare provider bonuses to quality standards that promote artery-clearing treatments over limb amputations and funds pilot programs for clinic-based prevention care.
People affected—The operative provisions cover all Medicare and Medicaid enrollees aged 65 and older as well as younger enrollees with specified cardiovascular risk factors, but the text does not specify an exact count of eligible beneficiaries.
Fiscal magnitude$30.0Mprovisional · pending reviewSection 2(399V–8)(c) authorizes $6,000,000 annually for fiscal years 2026 through 2030 ($30,000,000 total) for the education program. The broader mandatory spending impact on Medicare and Medicaid coverage expansions is not determinable from the text.
Reach58provisional · pending reviewrigor: heuristic llm
What this bill touches.
Government role in coverage+28
Who it helps · who it burdens.
Who it helps
- At-risk Medicare beneficiariesReceive 100 percent Medicare coverage without deductibles or coinsurance for peripheral artery disease (PAD) screening tests, including as part of the initial preventive physical exam (Sec. 3).
- At-risk Medicaid enrolleesReceive mandatory Medicaid coverage for peripheral artery disease (PAD) screening tests with no deductibles, copayments, or other cost-sharing (Sec. 4).
Who it burdens
- State Medicaid agenciesMust update state plans to cover peripheral artery disease screening tests for eligible at-risk enrollees and cannot impose any cost-sharing on those tests (Sec. 4).
- Medicare healthcare providers and suppliersMust comply with new Medicare quality measures related to lower-limb amputation prevention, diagnostic screening, and revascularization alternatives within quality reporting and incentive payment programs (Sec. 5).
Who backs it
- Federal taxpayersAuthorizes $6 million annually from fiscal years 2026 through 2030 to fund the peripheral artery disease public and professional education program (Sec. 2(399V–8)(c)).